Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021

US$ 3,000.00

16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 SUMMARY 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline...

April 2021 85 pages

23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021

US$ 3,000.00

23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 SUMMARY 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analysis on 23S Ribosomal RNA (23S rRNA) targeted pipeline...

April 2021 70 pages

30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021

US$ 3,000.00

30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021 SUMMARY 30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021 provides in depth analysis on 30S Ribosomal Subunit (30S RNA) targeted...

April 2021 40 pages

3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021

US$ 3,000.00

3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY 3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on 3C...

April 2021 60 pages

5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1...

April 2021 115 pages

5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or S...

April 2021 55 pages

5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D A...

April 2021 60 pages

5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021 provides in depth anal...

April 2021 45 pages

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in De...

April 2021 170 pages

5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxyt...

April 2021 50 pages

5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021 provid...

April 2021 60 pages

5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Developmen...

April 2021 40 pages

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Deve...

April 2021 40 pages

50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021

US$ 3,000.00

50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 SUMMARY 50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 provides in depth analysis on 50S Ribosomal Subunit (50S RNA) targeted...

April 2021 30 pages

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY 70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drugs in Development, 2021 provides in dept...

April 2021 35 pages

Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021

US$ 3,000.00

Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021 SUMMARY Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14)...

April 2021 30 pages

Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in Development, 2021

US$ 3,000.00

Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in Development, 2021 SUMMARY Acetyl CoA Carboxylase (Acetyl Coenzyme A Carboxylase or ACC or EC 6.4.1.2) - Drugs in...

April 2021 30 pages

Achromatopsia (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Achromatopsia (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Achromatopsia pipeline landscape. The...

April 2021 30 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorder...

April 2021 35 pages

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorder...

April 2021 35 pages

Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Acquired (Autoimmune) Hemolytic Anemia (Hematological Disorders) - Drugs in Development, 2021 prov...

April 2021 50 pages

Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Acral Lentiginous Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Acral Lentiginous Melanoma pip...

April 2021 30 pages

Acute Bronchitis (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Acute Bronchitis (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Bronchitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Bronchitis pipeline landscape. The rep...

April 2021 30 pages

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 SUMMARY Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome...

April 2021 50 pages

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 SUMMARY Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline lan...

April 2021 50 pages

Acute Inflammation (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Acute Inflammation (Immunology) - Drugs in Development, 2021 SUMMARY Acute Inflammation (Immunology) - Drugs in Development, 2021 provides an overview of the Acute Inflammation pipeline landscape. The...

April 2021 45 pages

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 SUMMARY Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute Ischem...

April 2021 125 pages

Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Acute Liver Failure (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Acute Liver Failure pipeline...

April 2021 45 pages

Acute Lung Injury (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Acute Lung Injury (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Lung Injury pipeline landscape. The...

April 2021 115 pages

Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Acute Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Acute Lymphoblastic Lympho...

April 2021 45 pages

Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021

US$ 2,000.00

Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021 SUMMARY Acute Opioid Overdosage (Toxicology) - Drugs in Development, 2021 provides an overview of the Acute Opioid Overdosage pipeline...

April 2021 40 pages

Acute Promyelocytic Leukemia (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Acute Promyelocytic Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY Acute Promyelocytic Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Acute Promyelocytic Leukem...

April 2021 35 pages

Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Respiratory Failure...

April 2021 30 pages

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021

US$ 2,000.00

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an...

April 2021 45 pages

Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute...

April 2021 35 pages

Addiction (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Addiction (Central Nervous System) - Drugs in Development, 2021 SUMMARY Addiction (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Addiction pipeline landscape. The re...

April 2021 45 pages

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 SUMMARY Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 provides an over...

April 2021 260 pages

Adenocarcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Adenocarcinoma pipeline landscape. The report provides...

April 2021 100 pages

Adenoid Cystic Carcinoma (ACC) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Adenoid Cystic Carcinoma (ACC) (Oncology) - Drugs in Development, 2021 SUMMARY Adenoid Cystic Carcinoma (ACC) (Oncology) - Drugs in Development, 2021 provides an overview of the Adenoid Cystic Carcino...

April 2021 60 pages

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) - Drugs in Development, 2021

US$ 3,000.00

Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) - Drugs in Development, 2021 SUMMARY Adenosine Monophosphate Activated P...

April 2021 120 pages

Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021

US$ 3,000.00

Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 SUMMARY Adenosine Receptor A1 (ADORA1) - Drugs in Development, 2021 provides in depth analysis on Adenosine Receptor A1 (ADORA1) targeted pi...

April 2021 45 pages

Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021

US$ 3,000.00

Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021 SUMMARY Adenosine Receptor A2a (ADORA2A) - Drugs in Development, 2021 provides in depth analysis on Adenosine Receptor A2a (ADORA2A) targe...

April 2021 90 pages

Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Adenoviridae Inf...

April 2021 55 pages

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) - Drugs in Development, 2021

US$ 3,000.00

Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Member I or ADIPOR1) - Drugs in Development, 2021 SUMMARY Adiponectin Receptor Protein 1 (Progestin And AdipoQ Receptor Family Memb...

April 2021 35 pages

ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC 3.2.2.6 or EC 2.4.99.20) - Drugs in Development, 2021

US$ 3,000.00

ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or E...

April 2021 50 pages

ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021

US$ 3,000.00

ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021 SUMMARY ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021 provides in depth analysis on ADP Ribosylation Factor 6 (ARF6) targe...

April 2021 30 pages

Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Adrenal Gland Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Adrenal Gland Cancer pipeline landscape. T...

April 2021 30 pages

Ageing (Other Diseases) - Drugs in Development, 2021

US$ 2,000.00

Ageing (Other Diseases) - Drugs in Development, 2021 SUMMARY Ageing (Other Diseases) - Drugs in Development, 2021 provides an overview of the Ageing pipeline landscape. The report provides comprehensi...

April 2021 105 pages

Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the...

April 2021 30 pages

Alcoholic Fatty Liver Disease (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Alcoholic Fatty Liver Disease (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Alcoholic Fatty Liver Disease (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Alcoholi...

April 2021 30 pages

Filters

Clear all